| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.09 | 0.08 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.089 | 0.08 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |